Equity Profile

A

Agilent Technologies, Inc.

Health CareLife Sciences Tools & Services$37.9B

Aug26Wed

Pre-Earnings Brief

UpcomingQ3-2026After Close5:00 PM EDT

Company Snapshot

Agilent Technologies, Inc. (A) operates in the health care sector, specifically within life sciences tools and services....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

$1.50

Revenue Growth

Revenue growth reflects the demand for Agilent's products and services, indicating overall business performance.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

A Q3-2026 Earnings Preview

Context

Company Snapshot

Agilent Technologies, Inc. (A) operates in the health care sector, specifically within life sciences tools and services. The company provides essential instruments and solutions for laboratories, which play a crucial role in drug development, diagnostics, and environmental testing.

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+2.40%

Avg Stock Reaction

+0.42%

Last Quarter Recap

In Q2-2026, Agilent reported an EPS of $1.49, exceeding estimates by 6.20%. The stock reacted positively, gaining 0.66% the following day.

Management Promises & Guidance

Focus on expanding product offerings in the life sciences sector.
Commitment to improving operational efficiencies.
Plans to enhance customer engagement through digital solutions.

Expectations

Wall Street Expectations

Overall, expectations for Agilent's upcoming earnings are mixed, with some analysts anticipating continued growth while others are cautious due to market conditions.

Bull Case

If Agilent beats EPS estimates and shows strong revenue growth, it could signal robust demand for its products, boosting investor confidence.

Bear Case

Conversely, if the company misses expectations or provides weak guidance, it could raise concerns about its growth trajectory and market competitiveness.

Key Metrics to Watch

Earnings Per Share (EPS)

$1.50

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

Revenue Growth

N/A

Revenue growth reflects the demand for Agilent's products and services, indicating overall business performance.

Gross Margin

N/A

Gross margin provides insight into the company's efficiency in managing production costs relative to sales.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the EPS for Q3-2026?

EPS is a critical measure of profitability, and a strong performance could reassure investors about Agilent's growth.

How is Agilent addressing competitive pressures in the life sciences sector?

Understanding the company's strategy in a competitive landscape will be crucial for assessing its future growth potential.

Edge

What the Street Is Missing

Why consensus could be wrong

The market may underestimate Agilent's ability to leverage its recent product innovations, which could drive stronger-than-expected revenue growth.

Supporting Evidence

The company has consistently beaten EPS estimates in the past, indicating strong operational execution.

Options pricing suggests a significant move, which may reflect investor uncertainty rather than a lack of confidence in the company's fundamentals.

Key Risk

If Agilent's revenue growth exceeds expectations, it could challenge the current cautious sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance will be closely watched as it reflects Agilent's ability to navigate market challenges and capitalize on growth opportunities.

Bull Confirmed If

An EPS of $1.50 or higher would confirm strong operational performance and growth.

Bear Confirmed If

An EPS below $1.40 could raise serious concerns about the company's profitability and market position.

Pre-Earnings Positioning

Options Market

Implied Move

±8.07%

Historical Avg

±0.5%

Pricing rich

The options market is pricing in a significant potential move, indicating that investors expect volatility around the earnings report.

Options are pricing ±8.1% while A has averaged ±0.5% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

56.2%

Calls (1.0M)P/C Ratio: 1.30Puts (345K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

This setup has occurred 30 times across Health Care in the last 2 years. 13 of 29 faded and 16 held — no strong directional bias after the initial reaction. The average absolute 1-day move is 5.5%, with a raw directional average of +2.9% (modestly positive historical bias).

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

History suggests that if Agilent beats expectations, the stock could rise by around 0.46%, confirming a positive outlook.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement as investors digest the details.

Miss

If Agilent misses estimates, history indicates a potential decline of about 0.29%, which could raise concerns about its growth strategy.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Updates on new product launches and their expected impact on revenue.
2Any commentary on market demand trends in the life sciences sector.
3Insights into cost management strategies and their effect on margins.
4Details on customer engagement initiatives and their success rates.
5Management's outlook on competitive dynamics in the industry.

See the full picture

AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.

No charge today · Auto-bills $8/mo after 7 days · Cancel anytime

More Earnings This Week

5 Reports

Sandisk Corporation

Company Snapshot

Agilent Technologies, Inc. (A) operates in the health care sector, specifically within life sciences tools and services....

Key Metrics to Watch

Earnings Per Share (EPS)

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

$1.50

Revenue Growth

Revenue growth reflects the demand for Agilent's products and services, indicating overall business performance.

N/A

1 more metrics, Wall Street expectations, options signals, track record, and call prep available with Pro.

A Q3-2026 Earnings Preview

Context

Company Snapshot

Earnings Scorecard·Last 8Q

EPS Beat Streak

EPS Beat Rate

75%

Avg EPS Surprise

+2.40%

Avg Stock Reaction

+0.42%

Last Quarter Recap

In Q2-2026, Agilent reported an EPS of $1.49, exceeding estimates by 6.20%. The stock reacted positively, gaining 0.66% the following day.

Management Promises & Guidance

Focus on expanding product offerings in the life sciences sector.
Commitment to improving operational efficiencies.
Plans to enhance customer engagement through digital solutions.

Expectations

Wall Street Expectations

Overall, expectations for Agilent's upcoming earnings are mixed, with some analysts anticipating continued growth while others are cautious due to market conditions.

Bull Case

If Agilent beats EPS estimates and shows strong revenue growth, it could signal robust demand for its products, boosting investor confidence.

Bear Case

Conversely, if the company misses expectations or provides weak guidance, it could raise concerns about its growth trajectory and market competitiveness.

Key Metrics to Watch

Earnings Per Share (EPS)

$1.50

EPS is a key indicator of the company's profitability and financial health, which investors closely monitor.

Revenue Growth

N/A

Revenue growth reflects the demand for Agilent's products and services, indicating overall business performance.

Gross Margin

N/A

Gross margin provides insight into the company's efficiency in managing production costs relative to sales.

Expectations

Two Questions That Matter

The print will turn on these two things.

What will be the EPS for Q3-2026?

EPS is a critical measure of profitability, and a strong performance could reassure investors about Agilent's growth.

How is Agilent addressing competitive pressures in the life sciences sector?

Understanding the company's strategy in a competitive landscape will be crucial for assessing its future growth potential.

Edge

What the Street Is Missing

Why consensus could be wrong

The market may underestimate Agilent's ability to leverage its recent product innovations, which could drive stronger-than-expected revenue growth.

Supporting Evidence

The company has consistently beaten EPS estimates in the past, indicating strong operational execution.

Options pricing suggests a significant move, which may reflect investor uncertainty rather than a lack of confidence in the company's fundamentals.

Key Risk

If Agilent's revenue growth exceeds expectations, it could challenge the current cautious sentiment.

Edge

Thesis-Break Levels

Pre-commit to what would confirm each case.

This quarter's performance will be closely watched as it reflects Agilent's ability to navigate market challenges and capitalize on growth opportunities.

Bull Confirmed If

An EPS of $1.50 or higher would confirm strong operational performance and growth.

Bear Confirmed If

An EPS below $1.40 could raise serious concerns about the company's profitability and market position.

Pre-Earnings Positioning

Options Market

Implied Move

±8.07%

Historical Avg

±0.5%

Pricing rich

The options market is pricing in a significant potential move, indicating that investors expect volatility around the earnings report.

Options are pricing ±8.1% while A has averaged ±0.5% over the last 8 prints — setup is pricing rich.

Detail

ATM IV

0.4%

30d HV

56.2%

Calls (1.0M)P/C Ratio: 1.30Puts (345K)

Edge

Historical Setup Match

Cross-company pattern from 30 similar setups.

Prior-quarter beat + options rich in Health Care

n=30

Fade rate: 13 of 29 (45%)

Preparation

Post-Print Playbook

Likely market behavior by outcome — not investment advice.

Beat & Raise

History suggests that if Agilent beats expectations, the stock could rise by around 0.46%, confirming a positive outlook.

In-Line / Cautious

If results are in line with expectations, the stock may see muted movement as investors digest the details.

Miss

If Agilent misses estimates, history indicates a potential decline of about 0.29%, which could raise concerns about its growth strategy.

Earnings Track Record

Preparation

What to Listen For

Call Prep

1Updates on new product launches and their expected impact on revenue.
2Any commentary on market demand trends in the life sciences sector.
3Insights into cost management strategies and their effect on margins.
4Details on customer engagement initiatives and their success rates.
5Management's outlook on competitive dynamics in the industry.